Daniel Yongwon Lee

Title: Innovations by Daniel Yongwon Lee

Introduction

Daniel Yongwon Lee is an accomplished inventor based in Tucson, AZ (US). He has made significant contributions to the field of immunotherapy and chemotherapy through his innovative research and patents. His work focuses on enhancing the efficacy of immune cells in targeting tumor cells.

Latest Patents

Daniel Yongwon Lee holds a patent for "Targeting moiety-drug grafted immune cell compositions and methods of use." This invention involves surface-engineered immune cells, such as natural killer cells, which are grafted with targeting moiety-drug complexes. The present invention combines chemotherapy and immunotherapy by engineering immune cells to specifically target tumor cells through antigen recognition. This method allows for the delivery of potent chemotherapeutic agents directly to the tumor cells, effectively destroying them. The surface-engineered immune cells can be prepared using a one-step method, and the invention also provides kits for preparing these cells. He has 1 patent to his name.

Career Highlights

Throughout his career, Daniel has worked with notable institutions, including the University of Arizona and the University of Utah Research Foundation. His research has contributed to advancements in cancer treatment and has the potential to improve patient outcomes significantly.

Collaborations

Daniel has collaborated with esteemed colleagues, including Youngwook Won and David A Bull, to further his research and innovations in the field.

Conclusion

Daniel Yongwon Lee's innovative work in the field of immunotherapy and chemotherapy showcases his dedication to advancing medical science. His patented inventions have the potential to revolutionize cancer treatment and improve the lives of many patients.